254 related articles for article (PubMed ID: 32850631)
1. Targeting Galectins With Glycomimetics.
Bertuzzi S; Quintana JI; Ardá A; Gimeno A; Jiménez-Barbero J
Front Chem; 2020; 8():593. PubMed ID: 32850631
[TBL] [Abstract][Full Text] [Related]
2. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
Front Oncol; 2016; 6():109. PubMed ID: 27242953
[TBL] [Abstract][Full Text] [Related]
3. Immunoprotective neo-glycoproteins: Chemoenzymatic synthesis of multivalent glycomimetics for inhibition of cancer-related galectin-3.
Heine V; Hovorková M; Vlachová M; Filipová M; Bumba L; Janoušková O; Hubálek M; Cvačka J; Petrásková L; Pelantová H; Křen V; Elling L; Bojarová P
Eur J Med Chem; 2021 Aug; 220():113500. PubMed ID: 33962190
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of galectins with small molecules.
Oberg CT; Leffler H; Nilsson UJ
Chimia (Aarau); 2011; 65(1-2):18-23. PubMed ID: 21469439
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of multivalent galactose-based dendrimer recognition by human galectin-7.
Ramaswamy S; Sleiman MH; Masuyer G; Arbez-Gindre C; Micha-Screttas M; Calogeropoulou T; Steele BR; Acharya KR
FEBS J; 2015 Jan; 282(2):372-87. PubMed ID: 25367374
[TBL] [Abstract][Full Text] [Related]
6. Glycomimetic inhibitors of tandem-repeat galectins: Simple and efficient.
Vrbata D; Červený J; Kulik N; Hovorková M; Balogová S; Vlachová M; Pelantová H; Křen V; Bojarová P
Bioorg Chem; 2024 Apr; 145():107231. PubMed ID: 38394919
[TBL] [Abstract][Full Text] [Related]
7. Human Milk Oligosaccharide Specificities of Human Galectins. Comparison of Electrospray Ionization Mass Spectrometry and Glycan Microarray Screening Results.
Shams-Ud-Doha K; Kitova EN; Kitov PI; St-Pierre Y; Klassen JS
Anal Chem; 2017 May; 89(9):4914-4921. PubMed ID: 28345865
[TBL] [Abstract][Full Text] [Related]
8. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs).
Sato S; St-Pierre C; Bhaumik P; Nieminen J
Immunol Rev; 2009 Jul; 230(1):172-87. PubMed ID: 19594636
[TBL] [Abstract][Full Text] [Related]
9. Galectin-Carbohydrate Interactions in Biomedicine and Biotechnology.
Laaf D; Bojarová P; Elling L; Křen V
Trends Biotechnol; 2019 Apr; 37(4):402-415. PubMed ID: 30413271
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for the recognition of carbohydrates by human galectin-7.
Leonidas DD; Vatzaki EH; Vorum H; Celis JE; Madsen P; Acharya KR
Biochemistry; 1998 Oct; 37(40):13930-40. PubMed ID: 9760227
[TBL] [Abstract][Full Text] [Related]
11. Galectins in acute and chronic inflammation.
Liu FT; Yang RY; Hsu DK
Ann N Y Acad Sci; 2012 Apr; 1253():80-91. PubMed ID: 22329844
[TBL] [Abstract][Full Text] [Related]
12. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
André S; Sansone F; Kaltner H; Casnati A; Kopitz J; Gabius HJ; Ungaro R
Chembiochem; 2008 Jul; 9(10):1649-61. PubMed ID: 18509838
[TBL] [Abstract][Full Text] [Related]
13. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
[TBL] [Abstract][Full Text] [Related]
14. Galectins: regulators of acute and chronic inflammation.
Liu FT; Rabinovich GA
Ann N Y Acad Sci; 2010 Jan; 1183():158-82. PubMed ID: 20146714
[TBL] [Abstract][Full Text] [Related]
15. Lectin-mediated drug targeting: selection of valency, sugar type (Gal/Lac), and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectins.
André S; Frisch B; Kaltner H; Desouza DL; Schuber F; Gabius HJ
Pharm Res; 2000 Aug; 17(8):985-90. PubMed ID: 11028946
[TBL] [Abstract][Full Text] [Related]
16. Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.
Vladoiu MC; Labrie M; Létourneau M; Egesborg P; Gagné D; Billard É; Grosset AA; Doucet N; Chatenet D; St-Pierre Y
Oncotarget; 2015 Dec; 6(38):40970-80. PubMed ID: 26543238
[TBL] [Abstract][Full Text] [Related]
17. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography.
Hirabayashi J; Hashidate T; Arata Y; Nishi N; Nakamura T; Hirashima M; Urashima T; Oka T; Futai M; Muller WE; Yagi F; Kasai K
Biochim Biophys Acta; 2002 Sep; 1572(2-3):232-54. PubMed ID: 12223272
[TBL] [Abstract][Full Text] [Related]
18. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.
Patnaik SK; Potvin B; Carlsson S; Sturm D; Leffler H; Stanley P
Glycobiology; 2006 Apr; 16(4):305-17. PubMed ID: 16319083
[TBL] [Abstract][Full Text] [Related]
19. Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design.
Hevey R
Biomimetics (Basel); 2019 Jul; 4(3):. PubMed ID: 31357673
[TBL] [Abstract][Full Text] [Related]
20. Microglial Lectins in Health and Neurological Diseases.
Siew JJ; Chern Y
Front Mol Neurosci; 2018; 11():158. PubMed ID: 29867350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
